Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Ganymed Pharmaceuticals GmbH
- Target Recruit Count
- 42
- Registration Number
- NCT02054351
- Locations
- 🇧🇪
UZ Brussels, Brussels, Belgium
🇧🇪UZ Leuven, Leuven, Belgium
🇩🇪Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany
Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer
- First Posted Date
- 2010-09-09
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Ganymed Pharmaceuticals GmbH
- Target Recruit Count
- 54
- Registration Number
- NCT01197885
- Locations
- 🇧🇬
Oncology Dispensary "Dr. Marko Markov", Varna, Bulgaria
🇧🇬MHAT "St.Marina", Varna, Bulgaria
🇧🇬Complex Oncology Center, Veliko Turnovo, Bulgaria
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
- Conditions
- Solid Tumors
- Interventions
- Drug: Claudiximab
- First Posted Date
- 2009-05-27
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Ganymed Pharmaceuticals GmbH
- Target Recruit Count
- 15
- Registration Number
- NCT00909025
- Locations
- 🇩🇪
Universitätsklinikum Essen, Innere Klinik (Tumorforschung), Essen, Germany
🇩🇪Universität Heidelberg, Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Germany
🇩🇪Johannes Gutenberg Universität, 1.Med Klinik und Poliklinik, Mainz, Germany